Literature DB >> 11904737

Syndecan-1 in B lymphoid malignancies.

R D Sanderson1, M Børset.   

Abstract

Syndecans are heparan sulfate-bearing proteoglycans that are found on the surface of most cells. Syndecan-1 is expressed predominantly on epithelia, but is also present on pre-B cells and plasma cells. The syndecans act to bind various effector molecules via their heparan sulfate chains, including both soluble and insoluble molecules within the extracellular milieu. These interactions promote cell adhesion to extracellular matrix and to adjacent cells. In addition, the syndecans can bind to and affect the biological activity of a number of heparin-binding growth factors. Thus, syndecan-1 can play a dramatic role in regulating cell behavior. In this review we discuss the expression of syndecan-1 on malignant B lymphoid cells as well as specific structure-function relationships of the molecule. Emphasis is placed on the important role that syndecan-1 has in regulating the growth of B lymphoid malignancies, particularly multiple myeloma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904737     DOI: 10.1007/s00277-002-0437-8

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  23 in total

1.  Association of heparan sulfate proteoglycans SDC1 and SDC4 polymorphisms with breast cancer in an Australian Caucasian population.

Authors:  Rachel K Okolicsanyi; Anne Buffiere; Jose M E Jacinto; Diego Chacon-Cortes; Suzanne K Chambers; Philippa H Youl; Larisa M Haupt; Lyn R Griffiths
Journal:  Tumour Biol       Date:  2014-11-01

Review 2.  CSPG4, a potential therapeutic target, facilitates malignant progression of melanoma.

Authors:  Matthew A Price; Leah E Colvin Wanshura; Jianbo Yang; Jennifer Carlson; Bo Xiang; Guiyuan Li; Soldano Ferrone; Arkadiusz Z Dudek; Eva A Turley; James B McCarthy
Journal:  Pigment Cell Melanoma Res       Date:  2011-12       Impact factor: 4.693

3.  Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actin bundling, and cell migration.

Authors:  Ritu Chakravarti; Vasileia Sapountzi; Josephine C Adams
Journal:  Mol Biol Cell       Date:  2005-06-01       Impact factor: 4.138

Review 4.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

5.  Th2 type inflammation promotes the gradual progression of HPV-infected cervical cells to cervical carcinoma.

Authors:  Qinghua Feng; Huafeng Wei; Janice Morihara; Joshua Stern; Mujun Yu; Nancy Kiviat; Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Gynecol Oncol       Date:  2012-07-22       Impact factor: 5.482

6.  Soluble syndecan-1 at diagnosis and during follow up of multiple myeloma: a single institution study.

Authors:  Ji Myung Kim; Jung Ae Lee; In Sung Cho; Chun Hwa Ihm
Journal:  Korean J Hematol       Date:  2010-06-30

7.  Comparative glycomics of leukocyte glycosaminoglycans.

Authors:  Chun Shao; Xiaofeng Shi; Mitchell White; Yu Huang; Kevan Hartshorn; Joseph Zaia
Journal:  FEBS J       Date:  2013-04-02       Impact factor: 5.542

8.  Mouse endometrial stromal cells and progesterone inhibit the activation and regulate the differentiation and antibody secretion of mouse B cells.

Authors:  Li Zhang; Kai-Kai Chang; Ming-Qing Li; Da-Jin Li; Xiao-Ying Yao
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

9.  Immunohistological profiling by B-cell differentiation status of primary central nervous system lymphoma treated by high-dose methotrexate chemotherapy.

Authors:  Manabu Kinoshita; Naoya Hashimoto; Shuichi Izumoto; Yoshiko Okita; Naoki Kagawa; Motohiko Maruno; Takanori Ohnishi; Norio Arita; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2010-01-13       Impact factor: 4.130

10.  XBP1 governs late events in plasma cell differentiation and is not required for antigen-specific memory B cell development.

Authors:  Derrick J Todd; Louise J McHeyzer-Williams; Czeslawa Kowal; Ann-Hwee Lee; Bruce T Volpe; Betty Diamond; Michael G McHeyzer-Williams; Laurie H Glimcher
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.